MHE3 Clinical Trial - Overcoming Obstacles

计划入组 192 人 · 首次发布于 2024 年 12 月 2 日

Assessing Deformable Image Registration in the Lung Using Hyperpolarized-gas MRI

计划入组 24 人 · 首次发布于 2016 年 12 月 16 日

Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET

计划入组 40 人 · 首次发布于 2022 年 10 月 18 日

NHE3 modulators, Ardelyx

Tenapanor(Ibsrela)

C₅₀H₆₆Cl₄N₈O₁₀S₂

YH-NCE3

Ardelyx Reports Strong 2025 Performance with IBSRELA Revenue Growing 73% and Launches Phase 3 Trial for Chronic Constipation

China Approves First-in-Class Tenapanor for Hyperphosphatemia in Dialysis Patients

Bone Resorption and Constipation Predict Higher Tenapanor Dose Requirements in Dialysis Patients with Hyperphosphatemia